Initial Performance of NI-RADS to Predict Residual or Recurrent Head and Neck Squamous Cell Carcinoma.
D A KriegerPatricia A HudginsGopi K NayakKristen BaugnonA S CoreyMihir R PatelJonathan J BeitlerNabil F SabaYuan LiuAshley AikenPublished in: AJNR. American journal of neuroradiology (2017)
The baseline performance of NI-RADS was good, demonstrating significant discrimination among the categories 1-3 for predicting disease.
Keyphrases